Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows

SCHAUMBURG, IL, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ:GIFT) (the "Company"), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards industry, today announced that CardCash.com is offering consumers smart saving solutions for high-cost GLP-1 weight loss prescription medications like Ozempic (semaglutide) from Novo Nordisk and Zepbound (tirzepatide) from Eli Lilly.

Read more at globenewswire.com